S144: IMMUNE RESTORATION AND SYNERGISTIC ACTIVITY WITH FIRST‐LINE (1L) IBRUTINIB (IBR) PLUS VENETOCLAX (VEN): TRANSLATIONAL ANALYSES OF CAPTIVATE PATIENTS WITH CLL
Solman, I., Singh Mali, R., Scarfo, L., Choi, M., Moreno, C., Grigg, A., Dean, J. P., Szafer‐Glusman, E.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
P670: ABSENCE OF BTK, BCL2, AND PLCG2 MUTATIONS IN RELAPSING CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AFTER FIRST‐LINE TREATMENT WITH FIXED‐DURATION IBRUTINIB (I) PLUS VENETOCLAX (V)
Croner, L. J., Allan, J. N., Jain, N., Seymour, J. F., Eckert, K., Cheung, L. W. K., Szafer‐Glusman, E.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
PB1878: CROSS‐TRIAL ANALYSIS OF FIXED‐DURATION IBRUTINIB (I) PLUS VENETOCLAX (V) VS FLUDARABINE (F), CYCLOPHOSPHAMIDE (C), AND RITUXIMAB (R) AS FIRST‐LINE TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Barrientos, J. C., Barr, P. M., Mato, A. R., Tam, C. S., Ghia, P., Moreno, C., Kay, N. E., Siddiqi, T., Szafer‐Glusman, E., Zhou, C., Neumayr, L., Krigsfeld, G., Wierda, W. G., Shanafelt, T.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P669: FIXED‐DURATION (FD) IBRUTINIB + VENETOCLAX FOR FIRST‐LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): 3‐YEAR FOLLOW‐UP FROM THE PHASE 2 CAPTIVATE STUDY FD COHORT
Moreno, C., Wierda, W. G., Barr, P. M., Siddiqi, T., Allan, J. N., Kipps, T. J., Trentin, L., Jacobs, R., Jackson, S., Tedeschi, A., Opat, S., Bannerji, R., Kuss, B. J., Croner, L. J., Szafer‐Glusman, E., Zhou, C., Szoke, A., Dean, J. P., Ghia, P., Tam, C. S.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
Detection of PD-L1 in circulating tumor cells and white blood cells from patients with advanced non-small-cell lung cancer
Ilié, M., Szafer-Glusman, E., Hofman, V., Chamorey, E., Lalvée, S., Selva, E., Leroy, S., Marquette, C.-H., Kowanetz, M., Hedge, P., Punnoose, E., Hofman, P.
Published in Annals of oncology (01.01.2018)
Published in Annals of oncology (01.01.2018)
Get full text
Journal Article
Evaluation of ctDNA in a phase I/II trial in relapsed or refractory large B‐cell lymphoma of epcoritamab, a novel, subcutaneous CD3xCD20 bispecific T‐cell–engaging antibody
Soong, D., Thieblemont, C., Karavitis, J., Hess, B., Caimi, P., Feldman, T., Hutchings, M., Sureda, A., Szafer‐Glusman, E., Sacchi, M., Jure‐Kunkel, M., Adya, N., Chiu, C.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
FIXED‐DURATION IBRUTINIB + VENETOCLAX IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): 4‐Y FOLLOW‐UP FROM THE FD COHORT OF THE PHASE 2 CAPTIVATE STUDY
Ghia, P., Allan, J. N., Siddiqi, T., Wierda, W. G., Tam, C. S., Moreno, C., Tedeschi, A., Szafer‐Glusman, E., Zhou, C., Abbazio, C., Dean, J. P., Szoke, A., Barr, P. M.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
PHASE 3 TRIAL OF SUBCUTANEOUS EPCORITAMAB + R‐CHOP VERSUS R‐CHOP IN PATIENTS (PTS) WITH NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): EPCORE DLBCL‐2
Sehn, L. H, Chamuleau, M., Lenz, G., Clausen, M. R., Haioun, C., Izutsu, K., Davies, A., Zhu, J., Oki, T., Szafer‐Glusman, E., Conlon, R., Chiou, H., Ipe, D., Elliot, B., Wu, J., Salles, G.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
CAPTIVATE PRIMARY ANALYSIS OF FIRST‐LINE TREATMENT WITH FIXED‐DURATION IBRUTINIB PLUS VENETOCLAX FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL)
Tam, C. S. L, Allan, J. N, Siddiqi, T, Kipps, T. J, Jacobs, R, Opat, S, Barr, P. M, Tedeschi, A, Trentin, L, Bannerji, R, Jackson, S, Kuss, B, Moreno, C, Szafer‐Glusman, E, Russell, K, Zhou, C, Ninomoto, J, Dean, J. P, Ghia, P, Wierda, W. G
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
REAL‐WORLD PROGNOSTIC IMPACT OF BCL2 AND MYC EXPRESSION AND TRANSLOCATION AMONG DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS TREATED WITH FIRST‐LINE R‐CHOP
Downer, M.K., Chaudhary, N., Szafer‐Glusman, E., Breuleux, M., Hsi, E.D., Biondo, J.M., Bazeos, A., Jiang, Y.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
PRECLINICAL EVALUATION OF EPCORITAMAB COMBINED WITH STANDARD OF CARE AGENTS FOR THE TREATMENT OF B‐CELL LYMPHOMAS
Chiu, C. W., Hiemstra, I. H., ten Hagen, W., Snijdewint‐Nkairi, R., de Jong, B., Garrido Castro, P., Kweekel, C., Oliveri, R. S., Elliot, B., Wielgos‐Bonvallet, M., Szafer‐Glusman, E., Schuurhuis, D., Blaedel, J., Ahmadi, T., Breij, E., Sasser, A.K., Jure‐Kunkel, M.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R‐CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY
Morschhauser, F., Flinn, I.W., Gasiorowski, R., Illés, Á., Feugier, P., Greil, R., Johnson, N.A., Larouche, J., Lugtenburg, P.J., Patti, C., Salles, G., Trněný, M., Vos, S., Mir, F., Kornacker, M., Punnoose, E.A., Samineni, D., Szafer‐Glusman, E., Petrich, A., Sinha, A., Spielewoy, N., Humphrey, K., Bazeos, A., Zelenetz, A.D.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
EVALUATION OF CLINICOGENETIC RISK MODELS FOR OUTCOME OF FOLLICULAR LYMPHOMA PATIENTS IN THE PRIMA TRIAL
Huet, S., Szafer‐Glusman, E., Xerri, L., Bolen, C., Punnoose, E., Tonon, L., Tilly, H., Brice, P., Feugier, P., Tesson, B., Viari, A., Venstrom, J.M., Salles, G.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023
Sehn, L H, Chamuleau, M, Lenz, G, Clausen, M R, Haioun, C, Izutsu, K, Davies, A, Zhu, J, Oki, T, Szafer-Glusman, E, Conlon, R, Chiou, H, Ipe, D, Elliot, B, Wu, J, Salles, G
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
PS1076 PROGNOSTIC IMPACT OF BCL2 AND MYC EXPRESSION AND TRANSLOCATION AMONG NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS TREATED WITH R‐CHOP IN THE REAL WORLD
Downer, M., Jiang, Y., Chaudhary, N., Breuleux, M., Szafer‐Glusman, E., Hsi, E.D., Biondo, J.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article
A Role for Very-Long-Chain Fatty Acids in Furrow Ingression during Cytokinesis in Drosophila Spermatocytes
Szafer-Glusman, Edith, Giansanti, Maria Grazia, Nishihama, Ryuichi, Bolival, Benjamin, Pringle, John, Gatti, Maurizio, Fuller, Margaret T.
Published in Current biology (23.09.2008)
Published in Current biology (23.09.2008)
Get full text
Journal Article
PHASE 3 TRIAL OF SUBCUTANEOUS EPCORITAMAB + R‐CHOP VERSUS R‐CHOP IN PATIENTS (PTS) WITH NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): EPCORE DLBCL‐2
Sehn, L. H, Chamuleau, M., Lenz, G., Clausen, M. R., Haioun, C., Izutsu, K., Davies, A., Zhu, J., Oki, T., Szafer‐Glusman, E., Conlon, R., Chiou, H., Ipe, D., Elliot, B., Wu, J., Salles, G.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
PF294 IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R‐CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY
Morschhauser, F., Feugier, P., Flinn, I.W., Gasiorowski, R., Greil, R., Illés, Á., Johnson, N.A., Larouche, J.‐F., Lugtenburg, P.J., Patti, C., Salles, G., Trněný, M., Vos, S., Mir, F., Kornacker, M., Punnoose, E., Samineni, D., Szafer‐Glusman, E., Petrich, A., Sinha, A., Spielewoy, N., Bazeos, A., Zelenetz, A.D.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article